Showing results (501-510 of 518) with videos related to
Sort By:
Pageof 52
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.Immunological Investigations|September 20, 2019
Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the DiseaseM Merle, D Fischbacher, A Liepert, et al.Immunobiology|April 10, 2021
Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactionsM Merle, D Fischbacher, A Liepert, et al.Frontiers in Immunology|April 30, 2024
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapyJames G Krueger, Kilian Eyerich, Vijay K Kuchroo, et al.Plos Pathogens|January 28, 2017
IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus InfectionGaia Muallem, Sagie Wagage, Yan Sun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology studyF Pein, J Michon, D Valteau-Couanet, et al.Pediatric Blood & Cancer|February 13, 2019
Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelinesYvan de la Monneraye, J Michon, H Pacquement, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse modelKimiko Nakajima, Takashi Kanda, Mikiro Takaishi, et al.British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.British Journal of Cancer|September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma GroupB De Bernardi, V Mosseri, H Rubie, et al.Pageof 52